Denbaars Steven 4

What Happened
Steven Denbaars, a director of Aeluma, sold a total of 25,000 shares in transactions on May 19–20, 2026, receiving aggregate proceeds of approximately $505,631. The sales reported were: 7,415 shares at a weighted average $19.56 ($145,026), 5,085 shares at $20.61 ($104,807), 11,558 shares at $20.40 ($235,734), and 942 shares at $21.30 ($20,064). These were sales (not purchases) and therefore are typically considered routine dispositions rather than a direct bullish signal.

Key Details

• Transaction dates: May 19 and May 20, 2026. Filing date: May 21, 2026 (appears timely).
• Reported weighted-average prices and reported price ranges per footnotes:
  • 7,415 shares @ $19.56 (sales ranged $19.02–$20.01).
  • 5,085 shares @ $20.61 (sales ranged $20.0244–$20.9963).
  • 11,558 shares @ $20.40 (sales ranged $19.89–$20.8895).
  • 942 shares @ $21.30 (sales ranged $20.907–$21.63).
• Proceeds: ~ $505,631 total.
• Sales were effected pursuant to a Rule 10b5‑1 trading plan adopted November 20, 2025.
• The filing notes restricted stock unit vesting schedule for other awards (1/12 on 12/31/25; quarterly and other vesting through 11/30/26).
• Shares owned after the transactions are not specified in the provided excerpt.

Context
Sales executed under a pre-established 10b5‑1 plan are common for insiders to systematically dispose of shares and are generally treated as routine. Such dispositions do not necessarily reflect the insider’s current view of the company’s prospects. Retail investors should consider these trades as one data point and review Aeluma’s broader fundamentals and disclosures before drawing investment conclusions.